Regen Biopharma Pref Shs (RGBPP) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	59.37K	59.06K	59.06K	59.06K
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	11.72K	210.00K	2.22K	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	170.70K	400.69K	210.56K	34.54K
Operating expense	182.42K	610.69K	212.77K	34.54K
Total operating expenses	182.42K	610.69K	212.77K	34.54K
Operating income	-123.06K	-551.62K	-153.71K	24.53K
Other non operating income	-349.22K	-380.83K	1.18M	-623.20K
EBT including unusual items	-572.47K	-967.85K	991.93K	-637.78K
EBT excluding unusual items	-572.47K	-967.85K	991.93K	-637.78K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-572.47K	-967.85K	991.93K	-637.78K
Net profit margin	-964.30%	-1,638.62%	1,679.38%	-1,079.80%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-100.20K	-35.40K	-36.04K	-39.11K
Net interest expenses	-100.20K	-35.40K	-36.04K	-39.11K
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance